Search Results 341-350 of 17540 for Cytology

  1. Combination Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Young Patients with Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma - Mayo Clinic

    Lumbar cerebral spinal fluid cytology positive for tumor cells by analysis of fluid collected either before definitive surgery or ≥ 10 days after definitive ...

  2. Overview - Optical Microscopy and Cell Analysis Core - Mayo Clinic Research

    BD FACSAria fusion flow cytometers. BD FACSCanto X clinical flow cytometry system. BD FACSMelody cell sorter. Bio-Rad ZE5 cell analyzer. Cytek Aurora spectral ...

  3. Low-grade UTUC Treated with Nadofaragene Firadenovec Administered to Renal Pelvis - Mayo Clinic

    UTUC characterised by one or more of the following: * High-grade cytology or high-grade histology * Multi-focal UTUC * Exception: Subjects with low-grade ...

  4. A Safety Study of SEA-TGT (SGN-TGT) in Patients With Advanced Cancer - Mayo Clinic

    - NSCLC: histological or cytological confirmed metastatic disease. Participants must have received no prior anti-PD-1/PD-L1 therapy allowed. - HNSCC ...

  5. Loncastuximab Tesirine in WM - Mayo Clinic

    shortness of breath) unless proven by cytology to be malignant due to WM. - Pregnant or breastfeeding. - Participants with known CNS lymphoma ...

  6. Vorinostat, Temozolomide, or Bevacizumab in Combination with Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients with Newly Diagnosed High-Grade Glioma - Mayo Clinic

    No positive CSF cytology. ECOG performance status (PS) 0-2. Karnofsky PS 50-100% (patients > 16 years of age); Lansky PS 50-100% (patients ≤ 16 years of age).

  7. Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL - Mayo Clinic

    Pleural effusion with positive cytology for lymphoma; Patients known to be HIV positive, hepatitis B positive, or hepatitis C positive; Known autoimmune ...

  8. Safety and Efficacy Study of MLN0128 in Combination With Exemestane or Fulvestrant in Postmenopausal Women With ER/PR+ Metastatic Breast Cancer - Mayo Clinic

    Histological or cytological confirmation of ER+ status (defined as > 1% positive tumor cells), and histological or cytological confirmation of HER2-negative ...

  9. Publications - Andras Khoor, M.D., Ph.D. - Mayo Clinic

    Subtyping of non-small cell lung cancer by cytology specimens: A proposal for resource-poor hospitals. Cytojournal. 2019; 16:8 Epub 2019 Apr 22. View PubMed ...

  10. A Study of CA-4948 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma - Mayo Clinic

    For participants limited to leptomeningeal involvement, cerebrospinal fluid (CSF) analysis (cytology and/or flow cytometry) with or without additional ...